
RedHill announces start of confirmatory Phase III Study of RHB-105 (Talicia)
RHB-105, newly branded as Talicia, a treatment of H. pylori infection, is now undergoing its confirmatory Phase III study, according to specialty biopharmaceutical firm RedHill […]